Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 47Leukemia 28Prostatic Neoplasms 21Burkitt Lymphoma 17Leukemia, Biphenotypic, Acute 15Lymphoma 13Leukemia, Myeloid, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large B-Cell, Diffuse 6Recurrence 5Lymphoma, Non-Hodgkin 5Myelodysplastic Syndromes 4Hodgkin Disease 4Pituitary Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Lymphoma, T-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, B-Cell 3Dendritic Cell Sarcoma, Interdigitating 3Breast Neoplasms 3Anemia, Refractory, with Excess of Blasts 3Rhabdoid Tumor 2Polycystic Ovary Syndrome 2Obesity 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Juvenile 2

Interventions

Interviews as Topic 13Specimen Handling 11Practice Guidelines as Topic 9Standard of Care 8Educational Status 7Methods 5Early Intervention, Educational 5Patient Navigation 4Health Promotion 3Acupressure 3Telemedicine 2Restraint, Physical 2Resistance Training 2Behavior Therapy 2Aromatherapy 2theanine 1ruxolitinib 1merphos 1lavender oil 1jojoba wax 1axatilimab 1X-Rays 1Triptorelin Pamoate 1Tacrolimus 1Surveys and Questionnaires 1Stem Cell Transplantation 1Spiritual Therapies 1Spinal Puncture 1Psychotherapy 1Psilocybin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematopoietic and Lymphatic System Neoplasm × Hydrocortisone × Clear all
NCT06895473 2026-01-30

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

OHSU Knight Cancer Institute

Phase 2 Recruiting
26 enrolled

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡